ONE in eight men in the UK will develop prostate cancer at some point in their lifetime and one man dies of the disease every hour of every day.Think about that for a second. Husbands, sons, brothers, uncles, nephews all across the UK are dying from prostate cancer - and the biggest...
The mainstay in the diagnosis of prostate cancer, aside from screening, which is a whole another controversial subject, is prostate biopsy. We've had a lot of recent advances in our ability to perform accurate prostate biopsies. One of those most important innovations, has been MRI fusion, ...
A single-blind study was conducted for evaluation of all images for prostate cancer diagnosis. Four board-certified and trained expert pathologists provided detailed labels in the form of free-form outlines encompassing tumors, indicating tumor regions (with grade) and other atypical manifestations on ...
prostate cancer; knockout mouse models; genetically-engineered mouse models; xenografts; patient derived xenografts; organoids; signaling pathways1. Introduction Historical Timeline of PCa Models In the United States, prostate cancer is estimated to be the most commonly diagnosed cancer in men in 2022...
(cancer OR carcinoma OR malignant OR lesions) AND (‘artificial intelligence’ OR ‘algorithm’ OR ‘deep learning’ OR ‘machine learning’ OR ‘automated classification’ OR ‘supervised learning’ OR ‘neural network’) AND (‘whole slide image’ OR ‘digital pathology’ OR pathomics OR ‘he...
Keywords: cancer;prostate;castration-resistant;noncoding RNA;snoRNA;sdRNA;CD44;CDK12;microRNA;ncRNA
Prostate cancer is one of the most common malignant diseases in men, and it contributes significantly to the increased mortality rate in men worldwide. This study aimed to review the roles of p300 and TMPRSS2 (transmembrane protease, serine 2) in the AR (androgen receptor) pathway as they ...